General Communication Submission

Confidential Business Information Claims under the Toxic Substances Control Act (TSCA) – Proposed Rule

8223-01_ICR_SupportingStmt_GeneralCommunications

OMB: 2070-0223

Document [pdf]
Download: pdf | pdf
CBI SUBMISSION

Submission Date: 04/15/2021

General Communication Submission
Submitting Official Information
Name of Authorized Official

William K Brigm an

CBI:

Company Name

CGI FEDERAL TEST 1

Position

Email Address

w illiam .brigm an@cgifederal.com

Phone Number

8289191634

Mailing Address 1

12601 FAIR LAKES CIRCLE

Mailing Address 2

null

City

FAIRFAX

State

VA

Postal Code

22033

Country

US

X

Part I. COMMUNICATION INFORMATION
Case Number

Office

OCSPP/OPPT

Communication Type

Chem icalINV-Section8bINV

Comments

test m essage

PMN Number

12040

Chemical Name

test chem ical nam e

CSRN

8132

Generic Name

test generic nam e

Accession Number

40120301

Chemical Name Check

true

CSRN Check

true

Generic Name Check

Accession Number Check
Message

CBI :

Y

Part II. Attachments
File Name

CBI

TEST ATTACHMENT-1.docx

Y

TSCA CBI Certification
I hereby certify to the best of my know ledge and belief that all information entered on this form is complete and accurate.
I further certify that, pursuant to 15 U.S.C. § 2613(c), for all claims for protection for any confidential information made w ith this submission, all information submitted to substantiate such claims is true and
correct, and that it is true and correct that the person submitting the claim has:
i.
ii.
iii.
iv.

taken reasonable measures to protect the confidentiality of the information;
determined that the information is not required to be disclosed or otherw ise made available to the public under any other Federal law ;
a reasonable basis to conclude that disclosure of the information is likely to cause substantial harm to the competitive position of the person; and
a reasonable basis to believe that the information is not readily discoverable through reverse engineering.

Any know ing and w illful misrepresentation is subject to criminal penalty pursuant to 18 U.S.C. § 1001.

Page 1

CBI SUBMISSION

Substantiation - Applicable to Any Claim
(i) Please specifically explain what harm to the competitive position of your business would be likely to result from the release of the information
claimed as confidential. How would that harm be substantial? Why is the substantial harm to your competitive position likely (i.e., probable) to be
caused by release of the information rather than just possible? If you claimed multiple types of information to be confidential (e.g. site information,
exposure information, environmental release information, etc.), explain how disclosure of each type of information would be likely to cause substantial
harm to the competitive position of your business.

CBI:

Yes
:No

✔

Test
(ii) Has your business taken precautions to protect the confidentiality of the disclosed information? If yes, please explain and identify the specific
measures, including but not limited to internal controls, that your business has taken to protect the information claimed as confidential. If the same or
similar information was previously reported to EPA as non-confidential (such as in an earlier version of this submission), please explain the
circumstances of that prior submission and reasons for believing the information is nonetheless still confidential.

CBI:

Yes
:No

✔

Test
(iii)(A) Is any of the information claimed as confidential required to be publicly disclosed under any other Federal law? If yes, please explain.

CBI:

Yes
:No

✔

Test
(iii) (B) Does any of the information claimed as confidential otherwise appear in any public documents, including (but not limited to) safety data sheets;
advertising or promotional material; professional or trade publications; state, local, or Federal agency files; or any other media or publications available
to the general public? If yes, please explain why the information should be treated as confidential.

CBI:

Yes
:No

✔

Test
(C) Has a patent been published for the chemical identity you claim confidential? What chemical identity information is not revealed by the patent? How
is release of that specific information likely to cause substantial competitive harm? And failure to explain this harm may lead to denial of your
confidentiality claim.

CBI:

Yes
:No

✔

Test
(iv) Is the claim of confidentiality intended to last less than 10 years (see TSCA section 14(e)(1)(B))? If yes, please indicate the number of years
(between 1-10 years) or the specific date after which the claim is withdrawn.

CBI:

Yes
:No

✔

Test
(v) Has EPA, another federal agency, or court made any confidentiality determination regarding information associated with this chemical
substance? If yes, please provide the circumstances associated with the prior determination, whether the information was found to be entitled to
confidential treatment, the entity that made the decision, and the date of the determination.

CBI:

Yes
:No

✔

Test

Substantiation - Chemical Identity Claim
(i)

Is this chemical substance publicly known (including by your competitors) to be in U.S. commerce? If yes, please explain why
the specific chemical identity should still be afforded confidential status (e.g., the chemical substance is publicly known only as
being distributed in commerce for research and development purposes, but no other information about the current commercial
distribution of the chemical substance in the United States is publicly available). If no, please complete the certification
statement:

CBI:

Yes
:No

✔

I certify that on the date referenced I searched the internet for the chemical substance identity (i.e., by both chemical substance
name and CASRN). I did not find a reference to this chemical substance that would indicate that the chemical is being
manufactured or imported by anyone for a commercial purpose in the United States. [provide date].
Test
(ii) Does this specific chemical substance leave the site of manufacture (including import) in any form, e.g., as a product, effluent,
emission? If yes, please explain what measures have been taken to guard against the discovery of its identity.

CBI:

Yes
:No

✔

Test

Page 2

CBI SUBMISSION

(ii) If the chemical substance leaves the site in a form that is available to the public or your competitors, can the chemical identity
be readily discovered by analysis of the substance (e.g., product, effluent, emission), in light of existing technologies and any
costs, difficulties, or limitations associated with such technologies? Please explain why or why not.

CBI:

Yes
:No

✔

Test
(iv) Would disclosure of the specific chemical identity release confidential process information? If yes, please explain.

CBI:

Yes
:No

✔

Test

Part VII - Certification
I hereby certify to the best of my knowledge and belief that all information entered on this form is complete and accurate. I further certify that, pursuant to 15 U.S.C. § 2613(c), for all claims for
protection of any confidential information made with this submission, all information submitted to substantiate such claims is true and correct, and that it is true and correct that I have:
(i) taken reasonable measures to protect the confidentiality of the information;
(ii) determined that the information is not required to be disclosed or otherwise made available to the public under any other Federal law;
(iii) a reasonable basis to conclude that disclosure of the information is likely to cause substantial harm to the competitive position of the person; and
(iv) a reasonable basis to believe that the information is not readily discoverable through reverse engineering.
Any knowing and willful misrepresentation is subject to criminal penalty pursuant to 18 U.S.C. § 1001.
Signature of authorized official: William Brigman

Date: 2021-08-24

Page 3


File Typeapplication/pdf
File Modified2021-12-02
File Created2021-04-15

© 2024 OMB.report | Privacy Policy